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Summary
Background.  —  The  Logistic  European  System  for  Cardiac  Operative  Risk  Evaluation  (EuroSCORE)
and the  Society  of  Thoracic  Surgeons  (STS)  score  are  routinely  used  to  identify  patients  at
Abbreviations: CABG, coronary artery bypass graft; EACTS, European Association of Cardio-Thoracic Surgery; ESC, European Society of
Cardiology; EuroSCORE, European System for Cardiac Operative Risk Evaluation; NYHA, New York Heart Association; STS, Society of Thoracic
Surgeons; TAVI, transcatheter aortic valve implantation.
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valve  implantation;
Risk  assessment
high  surgical  risk  as  potential  candidates  for  transcatheter  aortic  valve  implantation
(TAVI).
Aims. —  To  compare  the  new  EuroSCORE  II  with  the  Logistic  EuroSCORE  and  the  STS  score.
Methods.  —  From  October  2006  to  June  2011,  patients  with  severe  symptomatic  aortic  stenosis
who underwent  a  TAVI  were  enrolled  prospectively.
Results.  —  Among  272  patients,  the  EuroSCORE  II  was  signiﬁcantly  lower  and  moderately  cor-
related with  the  Logistic  EuroSCORE  (9  ±  8%  vs.  23  ±  14%,  P  <  0.01;  r  =  0.61,  P  <  0.001),  but
similar to  and  poorly  correlated  with  the  STS  (10  ±  9%,  P  =  0.10;  r  =  0.25,  P  <  0.001).  Based  on
recommended  high-risk  thresholds  (Logistic  EuroSCORE  ≥  20%;  STS  ≥  10%),  a  EuroSCORE  II  ≥  7%
provided the  best  diagnostic  value.  However,  using  the  EuroSCORE  II,  Logistic  EuroSCORE  or  STS
score, only  51%,  58%  and  37%  of  patients,  respectively,  reached  these  thresholds.  Contingency
analyses showed  that  agreements  between  the  EuroSCORE  II  and  the  Logistic  EuroSCORE  or  the
STS score  were  modest  or  poor,  respectively,  with  a  risk  assessment  different  in  28%  and  36%  of
patients, respectively.
Conclusions.  —  A  EuroSCORE  II  ≥  7%  corresponded  to  a  Logistic  EuroSCORE  ≥  20%  or  STS
score ≥  10%,  but  correlations  and  agreements  were  at  best  modest  and  only  approximately
half of  the  patients  reached  these  thresholds.  Our  results  highlight  the  limits  of  current  scoring
systems and  reinforce  the  European  guidelines  stressing  the  importance  of  clinical  judgment  in
addition to  risk  scores.
©  2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Le  Logistic  EuroSCORE  et  le  Society  of  Thoracic  Surgeons  (STS)  score  sont  utilisés
pour identiﬁer  les  patients  à  haut  risque  chirurgical  potentiellement  candidats  au  remplacement
valvulaire aortique  percutané  (TAVI).
Objectifs.  —  Comparer  l’EuroSCORE  II  avec  le  Logistic  EuroSCORE  et  le  STS  score.
Méthodes.  —  D’octobre  2006  à  juin  2011,  272  patients  traités  par  TAVI  pour  sténose  aortique
sévère symptomatique  ont  été  inclus  prospectivement.
Résultats.  —  L’EuroSCORE  II  était  plus  faible  et  modérément  corrélé  au  Logistic  EuroSCORE
(9 ±  8  %  vs  23  ±  14  %,  p  <  0,01  ;  r  =  0,61,  p  <  0,001),  mais  non  différent  et  médiocrement  corrélé
au STS  (10  ±  9  %,  p  =  0,10  ;  r  =  0,25,  p  <  0,001).  En  se  basant  sur  les  seuils  déﬁnissant  le  haut
risque chirurgical  (Logistic  EuroSCORE  ≥  20  %  ;  STS  ≥  10  %),  un  EuroSCORE  II  ≥  7  %  a  conduit  à  la
meilleure  valeur  diagnostique.  Cependant,  le  calcul  des  EuroSCORE  II,  Logistic  EuroSCORE  et
STS score  n’a  permis  d’atteindre  ces  seuils  que  dans  51  %,  58  %  et  37  %  des  cas,  respectivement.
L’analyse  de  contingence  a  révélé  que  l’accord  entre  EuroSCORE  II,  Logistic  EuroSCORE  ou  STS
score était  modéré  ou  médiocre  avec  une  stratiﬁcation  du  risque  différente  pour  28  %  et  36  %
des patients,  respectivement.
Conclusions.  — Un  EuroSCORE  II  ≥  7  %  correspond  à  un  Logistic  EuroSCORE  ≥  20  %  ou  un
STS ≥  10  %.  Les  corrélations  et  agréments  étaient  au  mieux  modestes  et  seulement  la  moitié  des
patients ont  atteint  ces  seuils.  Nos  résultats  conﬁrment  les  limites  des  scores  actuels  et  ren-
forcent les  recommandations  européennes  qui  soulignent  l’importance  de  l’évaluation  clinique
en complément  de  l’utilisation  des  scores.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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ince  its  introduction  in  2002  [1],  transcatheter  aortic  valve
mplantation  (TAVI)  has  become  increasingly  popular  for  the
reatment  of  severe  aortic  stenosis.  It  is  now  considered
 valuable  alternative  to  surgical  aortic  valve  replacement
or  patients  with  contraindications  to  surgery  or  those  con-
idered  to  be  at  high  surgical  risk  [2].  In  order  to  assess
atients’  operative  risk,  several  scoring  systems  have  been
eveloped.  The  European  System  for  Cardiac  Operative  Risk
valuation  (EuroSCORE)  [3,4]  and  the  Society  of  Thoracic
urgeons  (STS)  predicted  risk  of  mortality  score  [5,6]  are
t
S
r
phe  most  commonly  used.  The  European  society  recommends
o  consider  performing  a  TAVI  when  the  Logistic  EuroSCORE
s  ≥  20%  and/or  the  STS  score  is  ≥  10%  [7].
Recently,  the  EuroSCORE  II  has  been  proposed  as  an
pdated  version  of  the  Logistic  EuroSCORE  in  order  to
rovide  a better  assessment  of  the  perioperative  mortality
isk  of  patients  undergoing  open  heart  surgery,  especially
eart  valve  surgery  [8].  However,  comparisons  between
he  new  EuroSCORE  II  and  the  Logistic  EuroSCORE  and  the
TS  score  in  the  setting  of  TAVI  are  rare.  There  are  cur-
ently  limited  data  regarding  the  EuroSCORE  II  in  high-risk
atients  and  no  threshold  value  has  been  proposed  to  deﬁne
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high-risk  patients.  Thus,  the  aims  of  the  present  study  were
to:
• compare  the  EuroSCORE  II  to  the  Logistic  EuroSCORE  and
the  STS  score;
• determine  a  EuroSCORE  II  value  corresponding  to  the
Logistic  EuroSCORE  threshold  of  20%  and  the  STS  score
threshold  of  10%;
• evaluate  the  agreement  between  these  scoring  systems
with  regards  to  the  risk  classiﬁcation  for  surgery.
Methods
Study population
Consecutive  patients  with  severe  symptomatic  aortic  steno-
sis  who  underwent  a  TAVI  using  the  Edwards-Sapien  (Edwards
Lifesciences,  Irving,  CA,  USA)  or  the  Medtronic  CoreValve
(Medtronic,  Minneapolis,  MN,  USA)  prostheses  in  our  cardiol-
ogy  department  were  included  in  a  prospective  single-centre
registry.  All  procedures  were  performed  through  retrograde
transfemoral,  subclavian,  or  retroperitoneal  or  anterograde
transapical  approaches,  under  local  or  general  anaesthesia
[7].
Patients  were  considered  candidates  for  TAVI  based  on
a  Logistic  EuroSCORE  ≥  20%  or  because  of  frailty,  presence
of  severe  comorbidities  or  contraindication  to  surgical  aor-
tic  valve  replacement.  The  decision  to  perform  a  TAVI  was
validated  by  our  medico-surgical  heart  team.  All  patients
provided  signed  informed  consent  for  subsequent  data  col-
lection  and  analysis  for  research  purposes.
Clinical and echocardiographic characteristics
All  patients  were  initially  screened  in  order  to  conﬁrm  the
diagnosis  of  severe  symptomatic  aortic  stenosis.  Severe  aor-
tic  stenosis  was  deﬁned  as  an  aortic  valve  area  <  1.0  cm2
and/or  a  mean  transvalvular  gradient  >  40  mmHg  or  a  peak
velocity  >  4  m/sec  [9].  Data  concerning  history  of  coronary
artery  disease,  peripheral  artery  disease,  cerebrovascular
stroke,  renal  impairment  or  chronic  lung  disease  and  pre-
vious  cardiac  surgery  were  collected.  Porcelain  aorta  was
deﬁned  as  an  extensive  circumferential  calciﬁcation  of  the
ascending  aorta.  A  comprehensive  transthoracic  echocardi-
ography  was  performed  before  TAVI.
Risk score calculations
Predicted  operative  mortality  was  calculated  using  the
EuroSCORE  II,  the  Logistic  EuroSCORE  and  the  STS  score.
For  each  patient,  the  Logistic  EuroSCORE  [10]  and  the  STS
score  [11]  were  calculated  prospectively  using  web-based
systems.  The  EuroSCORE  II  was  calculated  retrospectively,
based  on  a  prospective  data  collection  of  items,  using  an
online  calculator  [10].
Statistical analysisVariables  are  expressed  as  mean  ±  standard  deviation  (SD)  or
number  (%).  Comparisons  between  scores  were  performed
using  paired  t-tests  and  linear  regressions.  The  diagnos-
tic  value  of  the  EuroSCORE  II  for  the  diagnosis  of  high
v
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perative  risk  (deﬁned  as  Logistic  EuroSCORE  ≥  20%  or  STS
core  ≥  10%)  was  analyzed.  Sensitivity,  speciﬁcity,  and  pos-
tive  and  negative  predictive  values  were  determined  for
arious  thresholds  of  the  EuroSCORE  II.  A  contingency  anal-
sis  was  performed  to  assess  the  agreement  between  the
ifferent  scores  with  regards  to  risk  classiﬁcation  for  surgery
nd  expressed  by  kappa  values.  A  high  kappa  value  demon-
trates  that  the  risk  classiﬁcation  of  patients  is  close  or
quivalent  using  the  two  scoring  systems.  Statistical  anal-
ses  were  performed  using  JMP  7  software  (SAS  institute,
ary,  NC,  USA).  P  <  0.05  was  considered  statistically  signiﬁ-
ant.
esults
atient characteristics
rom  October  2006  to  June  2011,  272  consecutive  patients
nderwent  a  TAVI  in  the  cardiology  department  of  Bichat
ospital,  Paris.  Demographic,  clinical  and  echocardiogra-
hic  characteristics  of  the  population  are  summarized  in
able  1. Brieﬂy,  mean  age  was  82  ±  9  years  and  44%  of
atients  were  female.  All  patients  had  severe  aortic  steno-
is.  A  large  proportion  of  patients  had  severe  symptoms,
ncluding  228  patients  (84%)  in  New  York  Heart  Association
NYHA)  class  III/IV.  TAVI  was  performed  using  the  trans-
emoral  approach  in  166  patients  (61%),  transapical  in  88
atients  (32%),  subclavian  in  15  (6%)  and  retroperitoneal  in
 patients  (1%);  under  general  anaesthesia  in  202  patients
74%)  or  local  anaesthesia  in  70  patients  (26%).
omparison between the EuroSCORE II, the
ogistic EuroSCORE and the STS score
he  mean  Logistic  EuroSCORE  was  23  ±  14%,  STS  score
0  ±  9%  and  EuroSCORE  II  9  ±  8%.  The  EuroSCORE  II  was  sig-
iﬁcantly  lower  than  the  logistic  EuroSCORE  (P  <  0.01),  but
ot  signiﬁcantly  different  to  the  STS  score  (P  =  0.10).  The
ean  EuroSCORE  II  was  signiﬁcantly  higher  in  patients  with
 Logistic  EuroSCORE  ≥  20%  (n  =  158  [58%])  than  in  those  with
 Logistic  EuroSCORE  <  20%  (n  =  114)  (12%  vs.  5%;  P  <  0.0001).
imilarly,  the  mean  EuroSCORE  II  was  signiﬁcantly  higher
n  patients  with  an  STS  score  ≥  10%  (n  =  101  [37%])  than
n  those  with  an  STS  score  <  10%  (n  =  171)  (12%  vs.  8%;
 =  0.0001).  However,  the  EuroSCORE  II  was  only  moderately
orrelated  with  the  Logistic  EuroSCORE  (r  =  0.61,  P  <  0.001)
Fig.  1A)  and  poorly  with  the  STS  score  (r  =  0.25,  P  <  0.001)
Fig.  1B).
etermination of the EuroSCORE II cut-off
alue for selecting high-risk patients
ensitivity,  speciﬁcity,  negative  predictive  values  and  posi-
ive  predictive  values  of  various  EuroSCORE  II  thresholds  are
resented  in  Tables  2  and  3. A  EuroSCORE  II ≥  7%  (observed
n  138  patients  [51%])  provided  the  highest  diagnostic
alue  (deﬁned  as  the  sum  of  the  sensitivity  and  speci-
city)  for  predicting  high  operative  risk  based  on  a  Logistic
uroSCORE  ≥  20%  (70%  sensitivity  and  75%  speciﬁcity)  and  an
TS  score  ≥  10%  (69%  sensitivity  and  60%  speciﬁcity).
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Table  1  Demographic,  clinical  and  echocardiographic
characteristics  of  the  study  population.
All  patients
(n =  272)
Age  (years)  82  ±  9
Female  119  (44)
History  of  smoking  91  (33)
Hypertension  204  (75)
Diabetes  mellitus 69  (25)
Insulin-dependent  diabetes  mellitus 17  (6)
Hypercholesterolaemia  141  (52)
Coronary  artery  disease  119  (44)
Prior  heart  valve  surgery  15  (6)
Prior  cerebrovascular  accident  26  (10)
Carotid  artery  stenosis  50  (18)
Peripheral  artery  disease  46  (17)
Chronic  pulmonary  obstructive  disease 78  (29)
Atrial  ﬁbrillation  103  (38)
Creatinine  clearance  (mL/min) 47  ±  24
Renal  failure  80  (29)
Porcelain  aorta 40  (15)
NYHA  class  III/IV  228  (84)
Canadian  Cardiovascular  Society  class  ≥  2 53  (19)
Mean  aortic  gradient  (mmHg)  51  ±  17
Aortic  valve  area  (cm2) 0.73  ±  0.19
Left  ventricular  ejection  fraction  <  50%  100  (37)
Systolic  pulmonary  artery  pressure  (mmHg) 50  ±  15
NYHA: New York Heart Association. Data are mean ± standard
deviation or number (%).
Figure 1. Correlations between the European System for Cardiac
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Table  2  Kappa  statistic  and  contingency  analyses  between  th
EuroSCORE  II
threshold
values  (%)
Logistic  EuroSCORE  ≥  20%
Kappa
values
Similarly
classiﬁed
Differently
classiﬁed
Sensitivity
(%)
≥  5  0.41  198  (73)  74  (27)  89  
≥  6  0.45  200  (74)  72  (26)  80  
≥  7  0.44  196  (72)  76  (28)  70  
≥  8  0.43  193  (71)  79  (29)  61  
≥  9  0.38  184  (68)  88  (32)  54  
≥  10 0.34  177  (65)  95  (35)  48  
EuroSCORE: European System for Cardiac Operative Risk Evaluation. Daperative Risk Evaluation (EuroSCORE) II and the Logistic EuroSCORE
A) and the Society of Thoracic Surgeons score (B).
greement between the EuroSCORE II,  the
ogistic EuroSCORE and the STS scoresing  a  EuroSCORE  II  threshold  value  of  ≥  7%  to  deﬁne  high-
isk,  the  agreement  with  the  Logistic  EuroSCORE  was  modest
kappa  =  0.44)  (Table  2).  Contingency  analyses  showed  that
96  patients  (72%)  were  similarly  classiﬁed  as  being  either
e  EuroSCORE  II  and  the  Logistic  EuroSCORE.
Speciﬁcity
(%)
Positive  predictive
values  (%)
Negative  predictive
values  (%)
50  71  77
64  76  70
75  80  64
84  84  61
87  85  58
89  85  55
ta are number (%).
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Table  3  Kappa  statistic  and  contingency  analyses  between  the  EuroSCORE  II  and  the  STS  score.
EuroSCORE  II
threshold
values  (%)
STS  score  ≥  10%
Kappa
values
Similarly
classiﬁed
Differently
classiﬁed
Sensitivity
(%)
Speciﬁcity
(%)
Positive  predictive
values  (%)
Negative  predictive
values  (%)
≥  5 0.15 143  (53) 129  (47)  84  34  43  78
≥  6 0.23 161  (59) 111  (41) 78  48  47  79
≥  7 0.27 173  (64) 99  (36) 69  60  51  77
≥  8 0.25 174  (64) 98  (36) 58  67  51  73
≥  9 0.22 173  (64) 99  (36) 51  71  51  71
≥  10 0.23 176  (65) 96  (35) 47  75  53  71
EuroSCORE: European System for Cardiac Operative Risk Evaluation; STS: Society of Thoracic Surgeons. Data are number (%).
Figure 2. Proportion of patients considered at high surgical risk
based on the European System for Cardiac Operative Risk Evaluationat  high  or  low  operative  risk  by  both  the  EuroSCORE  II
and  the  Logistic  EuroSCORE,  whereas  the  risk  assessment
was  different  in  76  patients  (28%)  (Table  2  and  Fig.  2).
Using  the  same  threshold  value  of  ≥  7%,  the  agreement
between  the  EuroSCORE  II  and  the  STS  score  was  poor
(kappa  =  0.27)  (Table  3).  Contingency  analyses  showed  that
only  173  patients  (64%)  were  similarly  classiﬁed  by  both  the
EuroSCORE  II  and  the  STS  score,  whereas  risk  assessment  was
different  in  99  patients  (36%)  (Table  3  and  Fig.  2).  It  is  worth
noting  that  the  agreement  between  the  Logistic  EuroSCORE
and  the  STS  score  using  the  recommended  threshold  values
of  20%  and  10%,  respectively,  was  also  poor  (kappa  =  0.23).
The  number  of  similarly  classiﬁed  patients  by  both  the
Logistic  EuroSCORE  and  the  STS  score  was  only  163  (60%)
(Fig.  2).
Discussion
In  this  series  of  patients  with  severe  aortic  stenosis  referred
for  TAVI,  we  found  that  the  mean  EuroSCORE  II  was  sig-
niﬁcantly  lower  than  the  Logistic  EuroSCORE,  and  that  the
correlation  between  these  scoring  systems  was  only  moder-
ate.  In  contrast,  although  the  mean  values  of  the  EuroSCORE
II  and  STS  score  were  not  signiﬁcantly  different,  the  cor-
relation  between  the  two  scores  was  poor.  A  EuroSCORE  II
cut-off  value  of  7%  corresponded  to  a  Logistic  EuroSCORE
of  20%  or  an  STS  score  of  10%.  However,  only  approxi-
mately  half  of  our  population  was  considered  at  high-risk
based  on  these  thresholds  and,  more  importantly,  the  agree-
ment  between  the  EuroSCORE  II  and  the  other  two  scores
regarding  risk  classiﬁcation  (high  or  low  surgical  risk)  and
thus  the  selection  of  patients  for  TAVI  was  only  modest,
with  28%  (EuroSCORE  II  vs.  Logistic  EuroSCORE)  to  36%
(EuroSCORE  II  vs.  STS  score)  of  patients  classiﬁed  differently.
The  assessment  of  surgical  risk  has  recently  gained  new
interest  with  the  development  of  TAVI  and  the  need  for
objective  and  quantitative  criteria  to  identify  patients
at  high  surgical  risk  and  thus  to  guide  clinical  decision-
making  [12].  Multivariable  scoring  systems  are  currently
the  only  means  of  reducing  subjectivity  of  risk  estimation.
The  EuroSCORE  was  elaborated  more  than  15  years  ago
using  data  from  19,030  patients  who  underwent  cardiac
(EuroSCORE) II (≥ 7%), Logistic EuroSCORE (≥ 20%) and Society of
Thoracic Surgeons score (≥ 10%) (A) and agreement between the
three scoring systems with regard to the risk stratiﬁcation based on
the above-mentioned thresholds (B).
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urgery  —  mainly  coronary  artery  bypass  graft  (CABG)  —  in
ight  European  countries  [3,4].  The  logistic  version  of  the
uroSCORE,  published  in  2003,  provided  an  improved  cal-
bration  compared  to  the  original  additive  model,  but  is
nown  to  markedly  overestimate  the  in-hospital  mortality
f  contemporary  surgery  [13—15].  The  STS  score,  however,
as  derived  from  a  larger  dataset  of  patients,  operated  on
n  a  more  recent  era,  and  speciﬁcally  considers  the  type  of
urgery.  It  also  includes  more  covariates  than  the  Logistic
uroSCORE,  is  the  most  detailed  risk  model  available  and  is
pdated  on  a  regular  basis.
The  EuroSCORE  II  was  developed  to  address  some  of
he  limitations  of  previous  scoring  systems  in  order  to
mprove  the  accuracy  for  predicting  the  operative  mortal-
ty  of  contemporary  cardiac  surgery.  It  was  elaborated  from
 contemporary  (2010)  large  series  of  patients  (n  =  22,381)
ho  underwent  CABG  or  valvular  surgery  in  similar  propor-
ions  [8].  The  EuroSCORE  II  incorporates  new  parameters
n  its  algorithm,  e.g.  NYHA  and  Canadian  Cardiovascular
ociety  classes.  The  degree  of  renal  impairment  has  been
urther  reﬁned,  with  a  classiﬁcation  based  on  the  creatinine
learance  level.  The  ejection  fraction,  the  pulmonary  artery
ystolic  pressure  and  the  degree  of  urgency  have  also  been
ategorized.  New  variables,  such  as  reduced  mobility  due  to
usculoskeletal  dysfunction  or  insulin-dependent  diabetes,
ave  been  included.  The  new  version  also  distinguishes  four
ifferent  types  of  surgical  procedures,  with  emphasis  on  the
eight  of  the  intervention.
In  the  present  study,  we  showed  that  predicted  mor-
ality  is  signiﬁcantly  lower  using  the  EuroSCORE  II  than
sing  the  Logistic  EuroSCORE.  Previous  studies  have  clearly
emonstrated  that  the  Logistic  EuroSCORE  signiﬁcantly
verestimated  the  operative  mortality  and  that  the  mis-
alibration  was  particularly  signiﬁcant  in  high-risk  patients
14,16—19].  The  lower  EuroSCORE  II  found  in  the  present
tudy  suggest  a  better  calibration  (ability  to  accurately  pre-
ict  the  operative  mortality)  than  the  Logistic  EuroSCORE,
nd  indeed  a  good  calibration  and  discrimination  (abil-
ty  to  differentiate  between  low-  and  high-risk  patients)
ave  been  reported  in  patients  with  isolated  aortic  valve
eplacement  or  aortic  valve  replacement  +  CABG  [20,21]. In
ontrast,  the  EuroSCORE  II  and  the  STS  score  were  not  sig-
iﬁcantly  different,  but  the  correlation  was  poor,  suggesting
hat  they  may  provide  different  calibration.
Using  cut-off  values  currently  recommended  to  deﬁne
igh  surgical  risk,  we  were  able  to  deﬁne  a  corresponding
hreshold  value  for  EuroSCORE  II.  Compared  to  both  the
ogistic  EuroSCORE  and  the  STS  score,  a  threshold  of  ≥  7%
rovided  the  best  diagnostic  value.  To  the  best  of  our  knowl-
dge,  this  is  the  ﬁrst  study  that  searched  for  correspondence
etween  these  scoring  systems  and  proposes  a  threshold  for
igh-risk  for  the  EuroSCORE  II.  Since  surgical  risk  factors
uch  as  frailty  or  porcelain  aorta  are  not  adequately  rep-
esented  in  all  scoring  systems,  42%  and  63%  of  our  patients
eferred  for  TAVI  did  not  reach  the  recommended  thresholds
Logistic  EuroSCORE  ≥  20%  or  STS  score  ≥  10%,  respectively).
imilarly,  almost  half  of  our  patients  did  not  reach  the
bove-mentioned  threshold  of  ≥  7%  for  the  EuroSCORE  II.
ore  importantly,  the  agreement  between  these  scoring
ystems  was  only  modest,  and  risk  assessment  was  differ-
nt  in  28%  (EuroSCORE  II  vs.  Logistic  EuroSCORE)  and  36%
EuroSCORE  II  vs.  STS  score)  of  patients.  Thus,  not  only
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re  current  scoring  systems  only  partially  capturing  factors
ssociated  with  high  surgical  risk,  they  are  also  selecting  dif-
erent  subsets  of  patients.  It  is  interesting  to  note  that  both
he  logistic  EuroSCORE  and  the  STS  score  were  not  different
n  the  PARTNER  A  and  PARTNER  B  trials  [22,23],  so  between
atients  considered  inoperable  and  those  considered  ‘only’
t  high-risk  but  operable  (29—30%  for  the  Logistic  EuroSCORE
nd  11—12%  for  the  STS  score).
In  a  recent  study  [20], the  EuroSCORE  II  performed  well
n  the  ﬁrst  tertile  of  risk  (the  majority  of  the  study  group),
ut  its  discrimination  dramatically  deteriorated  for  higher
ertiles,  where  its  performance  was  not  signiﬁcantly  better
han  the  Logistic  EuroSCORE  [20].  This  poor  discrimination
f  the  EuroSCORE  II  in  high-risk  patients  is  a  major  limitation
or  risk  assessment  in  candidates  for  a  TAVI.
Our  results  deserve  further  validation  in  larger  or  multi-
entre  studies,  but  clearly  highlight  the  limitations  of  the
se  of  current  scoring  systems  in  the  setting  of  TAVI.  These
ystems  should  not  be  used  as  isolated  tools,  which  is  in
greement  with  the  recently  updated  recommendations  of
he  European  Society  of  Cardiology  (ESC)  and  the  European
ssociation  of  Cardio-Thoracic  Surgery  (EACTS)  [2],  which
tate  that  ‘in  the  absence  of  a perfect  quantitative  score,
he  risk  assessment  should  mostly  rely  on  the  clinical  judg-
ent  of  the  heart  team,  in  addition  to  the  combination  of
cores.
The  present  study  has  several  limitations.  First,  the  three
coring  systems  were  developed  to  predict  perioperative
ortality  rather  than  in-hospital  mortality  after  TAVI.  Con-
equently,  we  did  not  compare  the  effective  in-hospital
ortality  after  TAVI  in  our  population  to  the  score-predicted
ortality.  It  is  well  known  that  the  performance  of  the
ogistic  EuroSCORE  system  is  poor  in  TAVI  patients  [24]
nd  speciﬁc  risk  scores  need  to  be  developed.  Second,
he  Logistic  EuroSCORE  and  the  STS  scores  were  calculated
rospectively  whereas  the  EuroSCORE  II  was  calculated  ret-
ospectively.  However,  all  the  data  needed  for  its  calculation
ere  recorded  prospectively  in  our  database.  Third,  we
nrolled  patients  who  underwent  a  TAVI  and  were  considered
t  high-risk  based  on  scores  and  clinical  judgment.  There-
ore,  one  may  argue  that  our  results  are  not  unexpected
r  tautological.  However,  as  many  as  half  of  our  popula-
ion  did  not  qualify  for  TAVI  based  on  scores  alone,  and  one
ain  result  of  our  study  is  to  show  that  the  three  scoring
ystems  (EuroSCORE  II,  Logistic  EuroSCORE  and  STS  score)
ften  disagree  and  lead  to  selection  of  different  subsets  of
atients  for  TAVI.  This  disagreement  is  a  major  limitation
or  patient  selection  in  the  setting  of  TAVI.  However,  we  are
ot  implying  that  scoring  systems  should  be  disregarded  or
bandoned.  Rather,  risk  estimation  should  be  encouraged,
ut  it  is  important  to  keep  in  mind  the  limitations  of  cur-
ent  scoring  systems  in  high-risk  patients  considered  for  TAVI
nd  these  scores  should  be  integrated  into  —  rather  than
ubstitute  —  clinical  judgement.
onclusionsn  this  series  of  high-risk  patients  referred  for  TAVI,
orrelations  between  the  new  EuroSCORE  II,  the  Logis-
ic  EuroSCORE  and  the  STS  score  were  at  best  modest.
 EuroSCORE  II  threshold  value  of  ≥  7%  corresponded  to
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a  Logistic  EuroSCORE  ≥  20%  and  an  STS  score  ≥  10%,  but
approximately  half  of  our  patients  did  not  reach  these
threshold  values  and  agreements  between  the  three  scoring
systems  was  poor.  Our  results  highlight  the  limits  of  current
scoring  systems  and  reinforce  current  ESC/EACTS  guidelines
on  the  management  of  valvular  heart  disease  recommen-
ding  an  integrative  approach  based  on  a  combination  of
scores  and  the  clinical  judgment  of  a  heart  team.  Speciﬁc
scores  aimed  at  predicting  outcomes  after  TAVI  need  to  be
developed  and  validated.
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